Update: 01.03.2021
Last week: 7 week 2022 (14.02.2022 - 20.02.2022)
Last full month: Jan 2021
| Time period | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | |||||||||
| WoW | 3 150 | 16.7% | 57.5% | 5.4 | 1 427 310 | 18.3% | 83.8% | 3.4 | 5.7% |
| MoM | 9 905 | 26.3% | 51.5% | 5.7 | 4 344 704 | 26.7% | 79.8% | 4 | 12.3% |
| YTD | 17 793 | 0.4% | 53.1% | -5.9 | 7 889 826 | 27.6% | 81.0% | -0.3 | 11.5% |
| MAT | 117 673 | -23.0% | 54.7% | -6.8 | 47 318 543 | 1.9% | 80.2% | -0.8 | -13.4% |
| CAPSICAM | |||||||||
| WoW | 23 138 | 0.5% | 3.5% | 0.1 | 9 462 766 | 0.9% | 3.6% | 0 | -2.4% |
| MoM | 98 524 | -7.4% | 3.6% | -0.5 | 40 398 608 | -6.6% | 3.8% | -0.5 | 5.6% |
| YTD | 159 012 | -12.1% | 3.5% | -0.2 | 65 078 129 | -14.7% | 3.7% | -0.7 | -7.1% |
| MAT | 1 043 157 | -20.9% | 3.1% | -0.3 | 427 749 204 | -12.2% | 3.4% | -0.4 | -13.3% |
| MILDRONATE | |||||||||
| WoW | 126 815 | 3.0% | 23.3% | 1.1 | 60 439 645 | 6.9% | 22.2% | 1.2 | -1.9% |
| MoM | 430 377 | 3.2% | 21.8% | -0.7 | 175 100 313 | 7.9% | 19.0% | 0 | 6.5% |
| YTD | 760 178 | 12.9% | 17.0% | 1.2 | 328 599 570 | 13.7% | 15.9% | 0.7 | 4.9% |
| MAT | 4 882 375 | 9.3% | 17.4% | 2.9 | 1 973 157 211 | 12.2% | 15.5% | 2.2 | -8.9% |
| SULFARGIN | |||||||||
| WoW | 3 862 | 13.1% | 1.1% | 0.1 | 1 831 750 | 11.9% | 1.5% | 0.1 | 2.6% |
| MoM | 13 779 | -21.2% | 0.9% | -0.3 | 6 745 395 | -20.1% | 1.3% | -0.3 | 4.0% |
| YTD | 22 965 | 3.4% | 1.0% | 0.1 | 11 128 206 | 7.7% | 1.3% | 0.3 | -7.5% |
| MAT | 164 912 | -20.9% | 0.8% | -0.1 | 80 555 094 | -9.1% | 1.2% | 0 | -11.6% |
| VIPROSAL | |||||||||
| WoW | 29 201 | -7.9% | 4.4% | -0.3 | 11 521 124 | -7.4% | 4.3% | -0.3 | -1.6% |
| MoM | 121 819 | -11.4% | 4.4% | -0.8 | 48 011 965 | -11.8% | 4.6% | -0.9 | 4.8% |
| YTD | 202 737 | 29.6% | 4.4% | 1.3 | 79 802 972 | 31.5% | 4.5% | 1.1 | -8.3% |
| MAT | 1 289 805 | -7.5% | 3.9% | 0.2 | 490 411 315 | -0.0% | 3.9% | 0.1 | -12.3% |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 3 150 | 16.7% | 57.5% | 5.4 | 1 427 310 | 18.3% | 83.8% | 3.4 | 5.7% |
| CAPSICAM | 23 138 | 0.5% | 3.5% | 0.1 | 9 462 766 | 0.9% | 3.6% | 0 | -2.4% |
| MILDRONATE | 126 815 | 3.0% | 23.3% | 1.1 | 60 439 645 | 6.9% | 22.2% | 1.2 | -1.9% |
| SULFARGIN | 3 862 | 13.1% | 1.1% | 0.1 | 1 831 750 | 11.9% | 1.5% | 0.1 | 2.6% |
| VIPROSAL | 29 201 | -7.9% | 4.4% | -0.3 | 11 521 124 | -7.4% | 4.3% | -0.3 | -1.6% |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 9 905 | 26.3% | 51.5% | 5.7 | 4 344 704 | 26.7% | 79.8% | 4 | 12.3% |
| CAPSICAM | 98 524 | -7.4% | 3.6% | -0.5 | 40 398 608 | -6.6% | 3.8% | -0.5 | 5.6% |
| MILDRONATE | 430 377 | 3.2% | 21.8% | -0.7 | 175 100 313 | 7.9% | 19.0% | 0 | 6.5% |
| SULFARGIN | 13 779 | -21.2% | 0.9% | -0.3 | 6 745 395 | -20.1% | 1.3% | -0.3 | 4.0% |
| VIPROSAL | 121 819 | -11.4% | 4.4% | -0.8 | 48 011 965 | -11.8% | 4.6% | -0.9 | 4.8% |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 17 793 | 0.4% | 53.1% | -5.9 | 7 889 826 | 27.6% | 81.0% | -0.3 | 11.5% |
| CAPSICAM | 159 012 | -12.1% | 3.5% | -0.2 | 65 078 129 | -14.7% | 3.7% | -0.7 | -7.1% |
| MILDRONATE | 760 178 | 12.9% | 17.0% | 1.2 | 328 599 570 | 13.7% | 15.9% | 0.7 | 4.9% |
| SULFARGIN | 22 965 | 3.4% | 1.0% | 0.1 | 11 128 206 | 7.7% | 1.3% | 0.3 | -7.5% |
| VIPROSAL | 202 737 | 29.6% | 4.4% | 1.3 | 79 802 972 | 31.5% | 4.5% | 1.1 | -8.3% |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 117 673 | -23.0% | 54.7% | -6.8 | 47 318 543 | 1.9% | 80.2% | -0.8 | -13.4% |
| CAPSICAM | 1 043 157 | -20.9% | 3.1% | -0.3 | 427 749 204 | -12.2% | 3.4% | -0.4 | -13.3% |
| MILDRONATE | 4 882 375 | 9.3% | 17.4% | 2.9 | 1 973 157 211 | 12.2% | 15.5% | 2.2 | -8.9% |
| SULFARGIN | 164 912 | -20.9% | 0.8% | -0.1 | 80 555 094 | -9.1% | 1.2% | 0 | -11.6% |
| VIPROSAL | 1 289 805 | -7.5% | 3.9% | 0.2 | 490 411 315 | -0.0% | 3.9% | 0.1 | -12.3% |
Abbreviations
WoW - Week Over Week Change = Sales of the last week / Sales of the previous week - 1
MoM - Month Over Month Change = Sales of the last full month / Sales of the previous full month - 1
YTD - Year to Date - a period of time beginning the first day of the current calendar year up to the current date
MAT - Moving Annual Total - a period, being any 12 month period ending on the last week
MS - Market Share
Data Sources:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs